Patent details

EP3943070 Title: LONG-ACTING FORMULATIONS OF BEDAQUILINE

Basic Information

Publication number:
EP3943070
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP211785266
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LONG-ACTING FORMULATIONS OF BEDAQUILINE
French Title of Invention:
FORMULATIONS À ACTION PROLONGÉE DE BEDAQUILINE
German Title of Invention:
LANGZEITWIRKENDE FORMULIERUNGEN VON BEDAQUILIN
SPC Number:

Dates

Filing date:
13/07/2018
Grant date:
22/11/2023
EP Publication Date:
26/01/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/11/2023
EP B1 Publication Date:
22/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/07/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/11/2023
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
NOVAGRAAF BREVETS
From:
22/12/2023
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

1

Name:
BASSTANIE, Esther, Dina, Guido
Address:
Belgium (BE)

2

Name:
Andries, Koenraad, Jozef, Lodewijk, Marcel
Address:
Belgium (BE)

3

Name:
BERNINI, Maristella
Address:
Belgium (BE)

Priority

1

Priority Number:
17181354
Priority Date:
14/07/2017
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
18167463
Priority Date:
16/04/2018
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/10; A61K 47/26; A61K 31/47; A61P 31/06; A61P 31/08;

Publication

European Patent Bulletin

1

Issue number:
202347
Publication date:
22/11/2023
Description:
Grant (B1)

2

Issue number:
202348
Publication date:
29/11/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/06/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
04/01/2024 Outgoing Correspondence 1
23/12/2023 Power Of Attorney 1